Indeed, an association between high AR expression and growth-inhibition by SPA in prostate cancer models has been observed (2, 12, 13), begging the question of whether high AR activity is necessary for prostate cancer sensitivity to SPA. The gene discussed is AR; the disease is prostate carcinoma.